<DOC>
	<DOCNO>NCT00223548</DOCNO>
	<brief_summary>The purpose study determine wether Mesna could prevent contrast-induced nephropathy</brief_summary>
	<brief_title>MESNA Prevention Acute Deterioration Renal Function Following Contrast Agent Application</brief_title>
	<detailed_description>Contrast-induced nephropathy remain common complication radiographic precedures . Pretreatment Mesna ( Sodium 2-mercaptoethane sulfonate ) combination sodium chloride protective sodium chloride alone animal model acute renal failure . The aim study therefore determine laboratory clinical benefit MESNA , adjunct saline hydration , patient know renal impairment receive contrast medium .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Mesna</mesh_term>
	<criteria>stable chronic renal insufficiency serum creatinine concentration &gt; 1,5 mg/dl Dialyzed patient patient acute renal failure receive iodinated contrast medium within 7 day study entry know allery Mesna , pregnancy , administration dopamine , mannitol Nacetylcysteine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2002</verification_date>
	<keyword>prophylaxis</keyword>
	<keyword>contrast-induced nephropathy</keyword>
	<keyword>mesna</keyword>
	<keyword>acute renal failure</keyword>
</DOC>